MGLN Magellan Health Inc

Price (delayed)

$94.6

Market cap

$2.48B

P/E Ratio

7.81

Dividend/share

N/A

EPS

$12.12

Enterprise value

$2.33B

Magellan Health, Inc., a Fortune 500 company, is a leader in managing the fastest growing, most complex areas of health, including special populations, complete pharmacy benefits and other specialty areas ...

Highlights
The stock's price to earnings (P/E) is 80% less than its 5-year quarterly average of 39.7 and 6% less than its last 4 quarters average of 8.3
Magellan Health's debt has decreased by 28% YoY
The net income has soared by 114% YoY but it fell by 21% QoQ
MGLN's EPS has soared by 109% year-on-year but it is down by 22% since the previous quarter
Magellan Health's gross margin has decreased by 36% YoY and by 19% from the previous quarter
Magellan Health's gross profit has decreased by 34% YoY and by 17% QoQ

Key stats

What are the main financial stats of MGLN
Market
Shares outstanding
26.26M
Market cap
$2.48B
Enterprise value
$2.33B
Valuations
Price to earnings (P/E)
7.81
Price to book (P/B)
1.28
Price to sales (P/S)
0.52
EV/EBIT
7.06
EV/EBITDA
5.36
EV/Sales
0.49
Earnings
Revenue
$4.74B
EBIT
$330.06M
EBITDA
$434.79M
Free cash flow
$64.95M
Per share
EPS
$12.12
Free cash flow per share
$2.49
Book value per share
$73.63
Revenue per share
$181.33
TBVPS
$87.26
Balance sheet
Total assets
$3.22B
Total liabilities
$1.26B
Debt
$524.69M
Equity
$1.92B
Working capital
$1.39B
Liquidity
Debt to equity
0.27
Current ratio
3.2
Quick ratio
2.91
Net debt/EBITDA
-0.35
Margins
EBITDA margin
9.2%
Gross margin
2.5%
Net margin
6.5%
Operating margin
0%
Efficiency
Return on assets
9.3%
Return on equity
16.9%
Return on invested capital
21%
Return on capital employed
12.8%
Return on sales
7%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

MGLN stock price

How has the Magellan Health stock price performed over time
Intraday
-0.02%
1 week
-0.08%
1 month
-0.1%
1 year
27.68%
YTD
14.2%
QTD
0.42%

Financial performance

How have Magellan Health's revenue and profit performed over time
Revenue
$4.74B
Gross profit
$117.59M
Operating income
-$463,000
Net income
$307.74M
Gross margin
2.5%
Net margin
6.5%
The net income has soared by 114% YoY but it fell by 21% QoQ
Magellan Health's net margin has surged by 103% YoY but it has decreased by 24% QoQ
Magellan Health's operating income has shrunk by 102% QoQ and by 101% YoY
Magellan Health's operating margin has plunged by 100% from the previous quarter and by 100% YoY

Growth

What is Magellan Health's growth rate over time

Valuation

What is Magellan Health stock price valuation
P/E
7.81
P/B
1.28
P/S
0.52
EV/EBIT
7.06
EV/EBITDA
5.36
EV/Sales
0.49
MGLN's EPS has soared by 109% year-on-year but it is down by 22% since the previous quarter
The stock's price to earnings (P/E) is 80% less than its 5-year quarterly average of 39.7 and 6% less than its last 4 quarters average of 8.3
MGLN's equity is up by 25% year-on-year
The P/B is 9% less than the 5-year quarterly average of 1.4 but 7% more than the last 4 quarters average of 1.2
MGLN's price to sales (P/S) is 30% higher than its 5-year quarterly average of 0.4 and 4% higher than its last 4 quarters average of 0.5
The revenue has grown by 4.9% year-on-year and by 2.6% since the previous quarter

Efficiency

How efficient is Magellan Health business performance
MGLN's return on invested capital has surged by 121% year-on-year but it is down by 7% since the previous quarter
MGLN's ROA has soared by 107% year-on-year but it is down by 21% since the previous quarter
MGLN's ROS has soared by 106% year-on-year but it is down by 15% since the previous quarter
The company's return on equity has surged by 69% YoY but it fell by 26% QoQ

Dividends

What is MGLN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for MGLN.

Financial health

How did Magellan Health financials performed over time
The total assets is 155% more than the total liabilities
Magellan Health's current ratio has soared by 56% YoY and by 4.6% from the previous quarter
Magellan Health's total liabilities has decreased by 30% YoY and by 2.6% from the previous quarter
Magellan Health's debt is 73% lower than its equity
MGLN's debt to equity is down by 43% YoY and by 3.6% QoQ
Magellan Health's debt has decreased by 28% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.